Literature DB >> 1545066

Multiple valve operation for advanced valvular heart disease: results and risk factors in 513 patients.

A C Galloway1, E A Grossi, F G Baumann, C L LaMendola, G A Crooke, L J Harris, S B Colvin, F C Spencer.   

Abstract

To assess the results and incremental risk factors affecting outcome after multiple-valve operation in the early blood cardioplegia era of cardiac surgery, follow-up data (mean +/- SD 3.1 +/- 2 years) were obtained on 97% of 513 patients (mean age +/- SD 58.8 +/- 10.5 years) who underwent a multiple-valve procedure between June 1976 and August 1985. Preoperatively 41% of patients were in New York Heart Association functional class III and 54% in class IV. Three groups accounted for 98.6% of the patients: 57.7% had an aortic and mitral valve procedure, 29% had a mitral and tricuspid valve procedure and 11.9% had a triple-valve procedure. The overall hospital mortality rate was 12.5% and overall 5-year survival rate was 67.1%. Hazard function analysis for all deaths revealed systolic pulmonary artery pressure (p less than 0.0001), age (p = 0.005), triple valve procedure (p less than 0.005), concomitant coronary bypass operation (p less than 0.005) and prior cardiac surgery (p less than 0.002) as the significant incremental risk factors predicting decreased survival in the early hazard phase; diabetes (p less than 0.005) predicted decreased survival in the late hazard phase. Postoperatively the condition of 80% of the patients improved to functional class I or II; only 0.6% remained in functional class IV. The 5-year rate of freedom from late combined valve-related morbidity was 81.7% and that of freedom from late combined valve-related morbidity and mortality was 71.7%. These results demonstrate excellent clinical improvement and late survival after multiple valve operation in patients with advanced valvular heart disease, justifying aggressive surgical therapy in these patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1545066     DOI: 10.1016/0735-1097(92)90509-l

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Short- and mid-term results of triple-valve surgery with an evaluation of postoperative quality of life.

Authors:  Saeed Davoodi; Abbasali Karimi; Seyed Hossein Ahmadi; Mehrab Marzban; Namvar Movahhedi; Kyomars Abbasi; Abbas Salehi Omran; Mahmood Shirzad; Mehrdad Sheikhvatan
Journal:  Tex Heart Inst J       Date:  2009

2.  Should a regurgitant mitral valve be replaced simulataneously with a stenotic aortic valve?

Authors:  J T Christenson; B Jordan; A Bloch; M Schmuziger
Journal:  Tex Heart Inst J       Date:  2000

Review 3.  Pathophysiology and management of multivalvular disease.

Authors:  Philippe Unger; Marie-Annick Clavel; Brian R Lindman; Patrick Mathieu; Philippe Pibarot
Journal:  Nat Rev Cardiol       Date:  2016-04-28       Impact factor: 32.419

4.  Should high risk patients with concomitant severe aortic stenosis and mitral valve disease undergo double valve surgery in the TAVR era?

Authors:  Pey-Jen Yu; Allan Mattia; Hugh A Cassiere; Rick Esposito; Frank Manetta; Nina Kohn; Alan R Hartman
Journal:  J Cardiothorac Surg       Date:  2017-12-29       Impact factor: 1.637

Review 5.  Transcatheter Aortic Valve Replacement and Concomitant Mitral Regurgitation.

Authors:  Barbara E Stähli; Markus Reinthaler; David M Leistner; Ulf Landmesser; Alexander Lauten
Journal:  Front Cardiovasc Med       Date:  2018-06-19

6.  Severe mitral regurgitation due to geometric changes in the mitral valve after surgical aortic valve replacement.

Authors:  Ryo Wakabayashi; Susumu Ide; Takashi Ishida; Satoshi Tanaka; Mikito Kawamata
Journal:  JA Clin Rep       Date:  2019-09-05

7.  Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement.

Authors:  Victor Mauri; Maria I Körber; Elmar Kuhn; Tobias Schmidt; Christian Frerker; Thorsten Wahlers; Tanja K Rudolph; Stephan Baldus; Matti Adam; Henrik Ten Freyhaus
Journal:  Clin Res Cardiol       Date:  2020-02-18       Impact factor: 5.460

8.  Impact of aortic valve replacement for severe aortic stenosis on organic and functional mitral regurgitation.

Authors:  Nahoko Kato; Jeremy J Thaden; William R Miranda; Christopher G Scott; Maurice E Sarano; Kevin L Greason; Patricia A Pellikka
Journal:  ESC Heart Fail       Date:  2021-10-15

9.  Short- and long-term results of triple valve surgery: a single center experience.

Authors:  Sung Ho Shinn; Sam-Sae Oh; Chan Young Na; Chang-Ha Lee; Hong-Gook Lim; Jae Hyun Kim; Kil Soo Yie; Man Jong Baek; Dong Seop Song
Journal:  J Korean Med Sci       Date:  2009-09-24       Impact factor: 2.153

10.  Mid-term effect of balloon aortic valvuloplasty on mitral regurgitation in aortic stenosis.

Authors:  Ryota Masaki; Masamichi Iwasaki; Hidekazu Tanaka; Tomoyo Hamana; Susumu Odajima; Wataru Fujimoto; Koji Kuroda; Yutaka Hatani; Takumi Inoue; Hiroshi Okamoto; Masanori Okuda; Takatoshi Hayashi; Ken-Ichi Hirata
Journal:  Cardiovasc Ultrasound       Date:  2020-04-13       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.